Navigation Links
Johnson & Johnson Highlights Strategies for Growth Through Differentiated Medicines, Transformational Pipeline and Global Product Launches
Date:5/26/2011

NEW BRUNSWICK, N.J., May 26, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will review growth strategies for its Pharmaceuticals business at a meeting with the investment community today.  Senior leaders from the company's executive committee and pharmaceuticals segment will review how the business plans to address some of the world's major unmet medical needs and outpace pharmaceutical market growth with an optimized product portfolio, robust pipeline and a demonstrated track record of successful global product launches.

"Our people focus every day on addressing the world's major unmet medical needs with superior science," said Vice Chairman, Executive Committee, Sheri McCoy.  "Since our last Pharmaceuticals Business Review with analysts in 2009, we have built a highly productive pharmaceuticals pipeline, with six key new products launching and another two pending regulatory review, some in multiple geographies.  Our disciplined approach to research and development, rigorous investment prioritization, and internal and external sources of innovation have enabled us to be well-positioned for long-term growth.  Our revitalized portfolio and launch capabilities have led to market leadership in key categories."

Johnson & Johnson's pharmaceuticals business will highlight its plans for continuing to address major medical needs and build on its market leadership in five therapeutic areas: Neuroscience; Cardiovascular and Metabolism; Immunology; Oncology and Infectious Diseases/Vaccines.  Brief summaries of the therapeutic areas, products and compounds being discussed in today's presentations are available in a separate backgrounder: Pharmaceuticals Segment Review Highlights.

Pharmaceuticals Growth
'/>"/>

SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
2. Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
3. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
4. Johnson & Johnson Announces Support for Kohl-Grassley Physician Payments Sunshine Act of 2009
5. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
6. Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
7. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
8. EF Johnson Technologies Announces Third Quarter Results
9. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
10. Johnson & Johnson to Participate in the 30th Annual Cowen and Company Health Care Conference
11. Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The non-invasive & minimally invasive cardiac output monitoring devices market is estimated ... Europe is segmented as Germany , U.K., ... Rest of Europe (RoE). Germany holds ... cardiac output monitoring devices market around 35.2% in 2014 followed by France ... , Sweden , Poland , Switzerland ...
(Date:4/21/2015)... 21, 2015 Whitehall-based ... dazzling export-led growth in just 4 years. ... part in winning the Queen,s Award for Enterprise, ... Oxford PharmaGenesis. As part of the world,s first ... bring new medicines to the world in areas ...
(Date:4/21/2015)... 2015 This report analyzes the worldwide markets ... Types: Equipment for Therapeutic Apheresis, and Equipment for Donor ... Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others. The report provides separate ... , Japan , Europe ... of World. Annual estimates and forecasts are provided for ...
Breaking Medicine Technology:European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
... -- Chindex International, Inc. (NASDAQ: ... care services in China through the operations of United ... and affiliated ambulatory clinics, today announced that the Company ... and first half of 2011, which ended June 30, ...
... Apnex Medical, Inc., received investigational device exemption (IDE) approval ... begin a clinical study to evaluate the safety and ... treat obstructive sleep apnea (OSA). Data from this clinical ... application for the HGNS System to the FDA. ...
Cached Medicine Technology:Chindex International, Inc. to Report Financial Results for the Second Quarter and First Half of 2011 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
(Date:4/21/2015)... The International Journal of Chronic Obstructive Pulmonary ... and its association with smoking in the Mainland China: ... from ten diverse areas ”. , As corresponding author ... of the world’s cigarettes, but the substantial increases in ... for the full eventual health consequences to be seen. ...
(Date:4/21/2015)... Francisco, CA and Orlando, FL (PRWEB) April 21, ... Behavioral Health (National Council) will honor Dina Tyler, ... Services for PREP (Prevention and Recovery in Early ... National Council Award of Excellence: Peer Specialist of ... awards ceremony, known as the Oscars of behavioral ...
(Date:4/21/2015)... Among parents of children with autism ... as fair or poor, according to a study in ... a visit to the dentist can present many challenges ... the strange smells, loud noises, and sharp tools; the ... of the whole process—not knowing what will happen and ...
(Date:4/21/2015)... The report “Sinusitis – ... on the therapeutic development for Sinusitis. The ... targets and MOAs to produce first-in-class and ... available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html . , ... in the therapeutic development for Sinusitis and ...
(Date:4/21/2015)... April 21, 2015 Wireless Analytics, ... has been recognized by the Boston Business Journal as ... ranking was announced at a recent event celebrating the ... of the fastest-growing private companies in Massachusetts. , Wireless ... the state that recorded the fastest revenue growth from ...
Breaking Medicine News(10 mins):Health News:COPD and smoking in the Mainland China published by Dove Medical Press 2Health News:COPD and smoking in the Mainland China published by Dove Medical Press 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
... ask people how much they plan to exercise, they,ll exercise morebut ... in the Journal of Consumer Research . "When people ... in a behavior (say, if the behavior is how much to ... in the next week makes them think about what they think ...
... Today, during the 89th General Session & Exhibition of ... with the 40th Annual Meeting of the American Association ... the Canadian Association for Dental Research, lead researcher Z. ... titled "Fuz is Essential for Craniofacial and Tooth Development." ...
... Today, during the 89th General Session & Exhibition ... conjunction with the 40th Annual Meeting of the American ... of the Canadian Association for Dental Research, lead researcher ... research study titled "Sealing Manifest Occlusal Caries in Permanent ...
... 17 (HealthDay News) -- It,s normal and healthy for ... housing assistance, according to a new study. The ... involves slacker young adults who refuse to grow up ... children,s development, said the researchers. They analyzed data ...
... HealthDay Reporter , THURSDAY, March 17 (HealthDay ... significantly improved the tremors, rigidity and other motor skill ... new study reports. The phase 2 study enrolled ... half randomly assigned to receive the gene therapy and ...
... Researchers at Boston University School of Medicine (BUSM), in ... new biomarker and therapeutic target for melanoma. The novel ... the process behind tumor metastasis and may allow the ... now appear online in Cancer Research . ...
Cached Medicine News:Health News:Getting healthy: When does prediction help people change their habits? 2Health News:Sealing manifest occlusal caries in permanent teeth -- 2.5-year results 2Health News:Young Adults May Need 'Safety Net' 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:Researchers discover possible biomarker and therapeutic target for melanoma 2
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
... has expanded memory capabilities for overnight sleep screening., ... oxygen saturation and pulse rate data, and can ... your needs:, ,1. The Model 130 can ... a single patient, making the device ideally suited ...
... Cost-effective, portable, continuous, or ... system with alarms and an ... Home-Use and Sleep Study modes ... in the hospital or clinical ...
... The Autocorr Plus, the fourth in ... versatile pulse oximeter/ECG/Respiration Monitor, with 3 ... digital oximetry with SAC (Serial Autocorrelation) ... electroluminescent screen display provides two user ...
Medicine Products: